Latest Innovation News

Wrkr Ltd has extended its partnership with MUFG Retirement Solutions to deliver an advanced digital platform for AustralianSuper, aiming to streamline employer services and align with upcoming superannuation reforms.

Imugene Limited has received a $5.87 million R&D tax refund, reinforcing its capacity to advance clinical trials in immuno-oncology. This funding milestone supports the development of its innovative cancer therapies, including CAR T cell treatments and oncolytic virotherapy.

Torque Metals has kicked off a fully funded 6,500-metre drilling campaign at its Paris Gold Project in Western Australia, aiming to expand its 250,000-ounce gold resource by targeting high-grade zones identified through advanced electromagnetic surveys.

Stealth Group Holdings has secured exclusive distribution rights for major global consumer brands in Australia and New Zealand, aiming to accelerate revenue growth and expand its digital footprint.

OpenLearning Limited has inked a five-year SaaS agreement with Education Centre of Australia, committing to support at least 2,500 students annually with its AI-powered learning platform. The deal highlights OpenLearning’s growing footprint in vocational and professional education sectors.

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Pro Medicus has secured a landmark 10-year, A$170 million contract to deploy its cloud-based Visage 7 imaging platform across UCHealth’s extensive hospital network in the US Rocky Mountain region.

Pro Medicus Limited has renewed a significant five-year contract with Franciscan Missionaries of Our Lady Health System, marking a strategic shift to cloud-based medical imaging solutions and promising new revenue streams.

PainChek Limited reports a robust quarter with a 10% rise in annual recurring revenue and expanding global client base, underpinned by strong licence retention and positive clinical validation.

The Calmer Co. International Limited has reported a striking 86% revenue jump to over AU$8 million in FY25, propelled by diversified sales channels and a strategic US expansion highlighted by new flavoured kava shots launched exclusively on Amazon USA.

BCAL Diagnostics has secured a strategic partnership with Cancer Care Associates to fast-track the clinical adoption and revenue generation of its innovative BREASTEST plus™ breast cancer blood test starting FY2026.

Gold Hydrogen has attracted a $14.5 million strategic investment from global energy leaders Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, following promising drilling results in South Australia. The funds will accelerate exploration and commercialisation of natural hydrogen and helium resources.